Tenax Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2017
Total Assets: $9.9M
Liabilities Breakdown FY2017
Total Liabilities: $1.0M
Asset Breakdown
Total Assets: $9.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.6M | 16.2% |
| Accounts Receivable | $50.2K | 0.5% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $9.9K | 0.1% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $8.2M | 83.2% |
Liabilities Breakdown
Total Liabilities: $1.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $611.9K | 60.6% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $397.0K | 39.4% |